Sorted By:

Relevance


More Than 240 Innovative Medicines in Development For Leukemia, Lymphoma and Other Blood Cancers

PhRMA  |  Press Release

The Medicines in Development for Leukemia, Lymphoma and Other Blood Cancers report, as well as an overview and other supplementary materials, are available on PhRMA’s website at http://phrma.org/meds-in-development.
https://www.phrma.org/press-release/more-than-240-innovative-medicines-in-development-for-leukemia-lymphoma-and-other-blood-cancers

PhRMA Statement on Ongoing Investments in Domestic Innovation

PhRMA  |  Press Release

“While the U.S. retains an advantage in medical innovation, it’s ours to lose to global competitors such as China, Brazil and India.
https://www.phrma.org/press-release/phrma-statement-on-ongoing-investments-in-domestic-innovation

#RarePOV Conversation Generates Strong Enthusiasm for Rare Disease Day on February 28th

PhRMA  |  Blog Post

@Taylorstale shared a recent article in Runner’s World that highlighted Batten’s disease and suggested patient advocates contact local media to discuss progress in medical research.
http://catalyst.phrma.org/rarepov-conversation-generates-strong-enthusiasm-for-rare-disease-day-on-february-28th

Lauren Levinson Named PhRMA Vice President of Communications

PhRMA  |  Press Release

She provided strategic communications counsel on a variety of policy issues in the evolving health care landscape, including implementation of the Affordable Care Act, the creation of a regulatory pathway for biosimilars and efforts to repeal the medical device tax.
https://www.phrma.org/press-release/lauren-levinson-named-phrma-vice-president-of-communications

Alzheimer's Webinar - July 15, 2015 at 1:30 pm EDT

PhRMA  |  Video

  New Report: Alzheimer’s Research “Setbacks” Critical for Breakthroughs of TomorrowRead PhRMA's Press Release on the Summer 2015 report
https://www.phrma.org/video/alzheimer-s-webinar-july-15-2015-at-1-30-pm-edt

PhRMA Statement on 2016 Special 301 Report

PhRMA  |  Press Release

PhRMA members welcome USTR’s decision to maintain India on the Priority Watch List and the emphasis the Special 301 Report places on achieving substantive and measurable results.
https://www.phrma.org/press-release/phrma-statement-on-2016-special-301-report

Access Patient Resources

PhRMA  |  From PhRMA

Understanding the medical and pharmaceutical landscape is an essential – and oftentimes, first – step for any patient and their loved ones after a diagnosis.
https://www.phrma.org/patients/access-patient-resources

Week in Review: The Latest from PhRMA

PhRMA  |  Blog Post

See this week’s post for a breakdown of Medicare spending.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-september-25-2015

ICYMI – NYT: Unable to Meet the Deductible or the Doctor

PhRMA  |  Blog Post

For example, a recent report from Milliman round that Silver plans are nearly four times more likely to have a single combined deductible for medical and pharmacy benefits compared to typical employer-sponsored plan.
http://catalyst.phrma.org/icymi-nyt-unable-to-meet-the-deductible-or-the-doctor

PhRMA Recognizes 2016 Research & Hope Award Recipients

PhRMA  |  Press Release

“The Lupus Foundation of America has established a national medical research program that is based on establishing smarter research to achieve faster progress.
https://www.phrma.org/press-release/phrma-recognizes-2016-research-and-hope-award-recipients

New Report Shows Colorado Clinical Trials Benefit State’s Health and Economy

PhRMA  |  Press Release

Find PhRMA Online: Website – http://www.phrma.org facebook – www.facebook.com/PhRMA Blog – www.phrma.org/catalyst Twitter – www.Twitter.com/PhRMA and www.Twitter.com/PhRMApress YouTube – www.youtube.com/PhRMApress For information on how innovative medicines save lives, visit: http://www.innovation.org For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org For information on ensuring the flow of medicines during public health emergencies, visit http://www.rxresponse.org
https://www.phrma.org/press-release/new-report-shows-colorado-clinical-trials-benefit-state-s-health-and-economy

Code on Interactions With Health Care Professionals

PhRMA  |  Codes & Guidelines

The Code is based on the principle that a healthcare professional’s care of patients should be based, and should be perceived as being based, solely on each patient’s medical needs and the healthcare professional’s medical knowledge and experience.
https://www.phrma.org/codes-and-guidelines/code-on-interactions-with-health-care-professionals

340B Spotlight: 340B hospitals account for majority of Part B reimbursements

PhRMA  |  Blog Post

The current unsustainable growth of the 340B program has been driven by expanded hospital eligibility criteria, hospital acquisition of physician practices, multiple contract pharmacy arrangements and more.
http://catalyst.phrma.org/340b-spotlight-340b-hospitals-account-for-majority-of-part-b-reimbursements

ICYMI: Higher out-of-pocket costs in health insurance exchange plans compared to employer plans for patients managing chronic conditions

PhRMA  |  Blog Post

Researchers found increases out-of-pocket spending would reduce prescription fills and increase spending on other medical services.
http://catalyst.phrma.org/icymi-higher-out-of-pocket-costs-in-health-insurance-exchange-plans-compared-to-employer-plans-for-patients-managing-chronic-conditions

Insurers Increase Cost-Sharing Measures For Specialty Drugs

Access Better Coverage  |  From Our Network

But insurers are pushing back against the rising costs of specialty meds, especially hepatitis C drug Sovaldi.
http://www.accessbettercoverage.org/social-news/insurers-increase-cost-sharing-measures-for-specialty-drugs

Keeping the Wheels Turning on Patent Reform

PhRMA  |  Blog Post

Just as we celebrate today's medical breakthroughs, we need a reliable patent system that helps to stimulate tomorrow's big ideas.
http://catalyst.phrma.org/keeping-the-wheels-turning-on-patent-reform

ICYMI: Next Generation Cures

PhRMA  |  Blog Post

If you missed the conversation, check out the recap on social media on Storify or watch the video below.
http://catalyst.phrma.org/icymi-next-generation-cures

Research in North Carolina

PhRMA  |  Research In Your Backyard

Biopharmaceutical research companies are conducting or have conducted more than 7,200 clinical trials of new medicines in collaboration with the state’s university medical schools, clinical research centers and hospitals (2004 to present).
https://www.phrma.org/research-in-your-backyard/research-in-north-carolina

PhRMA Statement on Foreign Clinical Trials - 2009

PhRMA  |  Press Release

“The PhRMA Principles for the Conduct of Clinical Trials and Communication of Clinical Trial Results, created in 2002 and updated in 2004, have been a valuable guide to member companies and underscore our commitment to the safety of clinical trial participants and communication of important medical findings from clinical trials.
https://www.phrma.org/press-release/phrma-statement-on-foreign-clinical-trials-2009

ICYMI: Debunking Myths about Cancer Care in the United States

PhRMA  |  Blog Post

Myth 4: Cancer Treatment At The End Of Life Is Of Low Value Reality:  According to Goldman and Philipson, “coverage decisions based solely on median survival will neglect the great social value for a minority who live long after the trial ends.
http://catalyst.phrma.org/icymi-debunking-myths-about-cancer-care-in-the-united-states

Medicare Monday: What is ASP?

PhRMA  |  Blog Post

Spending on Part B drugs provided by physicians and hospital outpatient departments represents just 3 percent of total Medicare expenditures and has remained flat as a share of total expenditures in Part B (8 percent). 
http://catalyst.phrma.org/medicare-monday-what-is-asp

PhRMA Statement Regarding Research Partnerships and Clinical Trials

PhRMA  |  Press Release

“It takes many different partners to make medical progress a reality.
https://www.phrma.org/press-release/phrma-statement-regarding-research-partnerships-and-clinical-trials

340B Spotlight: Health Care Costs Rising from Increase in 340B Hospital Acquisitions of Physician Practices

PhRMA  |  Blog Post

 This trend is helping drive unprecedented program growth and raising health care costs for patients and payers given the more expensive treatment setting.
http://catalyst.phrma.org/340b-spotlight-health-care-costs-rising-from-increase-in-340b-hospital-acquisitions-of-physician-practices

Josephine Martin Joins PhRMA as Exec VP of Public Affairs

PhRMA  |  Press Release

Prior to building a public affairs health care practice at Ketchum, Martin served in leading public affairs positions at Golin Harris and National Media, Inc.
https://www.phrma.org/press-release/josephine-martin-joins-phrma-as-exec-vp-of-public-affairs

PhRMA Statement Regarding Pediatric Reauthorization

PhRMA  |  Press Release

Find PhRMA Online: Website – http://www.phrma.org facebook – www.facebook.com/PhRMA Blog – www.phrma.org/catalyst Twitter – www.Twitter.com/PhRMA and www.Twitter.com/PhRMApress YouTube – www.youtube.com/PhRMApress For information on how innovative medicines save lives, visit: http://www.innovation.org For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org For information on ensuring the flow of medicines during public health emergencies, visit http://www.rxresponse.org
https://www.phrma.org/press-release/phrma-statement-regarding-pediatric-reauthorization

You have reviewed the first 275 results out of 1044. Each page contains 25 results. You're on page 11.

prev 7 8 9 10 11 12 next